Biocardia Stock Market Value
| BCDA Stock | USD 2.28 0.09 3.80% |
| Symbol | Biocardia |
Biocardia Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. If investors know Biocardia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocardia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.264 | Quarterly Revenue Growth (0.93) | Return On Assets (1.16) | Return On Equity (7.04) |
The market value of Biocardia is measured differently than its book value, which is the value of Biocardia that is recorded on the company's balance sheet. Investors also form their own opinion of Biocardia's value that differs from its market value or its book value, called intrinsic value, which is Biocardia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocardia's market value can be influenced by many factors that don't directly affect Biocardia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocardia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biocardia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocardia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biocardia 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biocardia's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biocardia.
| 12/14/2022 |
| 12/03/2024 |
If you would invest 0.00 in Biocardia on December 14, 2022 and sell it all today you would earn a total of 0.00 from holding Biocardia or generate 0.0% return on investment in Biocardia over 720 days. Biocardia is related to or competes with Aerovate Therapeutics, Adagene, Acrivon Therapeutics,, Rezolute, AN2 Therapeutics, Erasca, and Forte Biosciences. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for car... More
Biocardia Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biocardia's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biocardia upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.76 | |||
| Information Ratio | 0.0394 | |||
| Maximum Drawdown | 106.86 | |||
| Value At Risk | (10.10) | |||
| Potential Upside | 8.68 |
Biocardia Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biocardia's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biocardia's standard deviation. In reality, there are many statistical measures that can use Biocardia historical prices to predict the future Biocardia's volatility.| Risk Adjusted Performance | 0.0474 | |||
| Jensen Alpha | 0.1818 | |||
| Total Risk Alpha | (1.21) | |||
| Sortino Ratio | 0.0697 | |||
| Treynor Ratio | 0.1657 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biocardia Backtested Returns
Biocardia secures Sharpe Ratio (or Efficiency) of -0.0096, which signifies that the company had a -0.0096% return per unit of risk over the last 3 months. Biocardia exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biocardia's Mean Deviation of 5.97, risk adjusted performance of 0.0474, and Downside Deviation of 6.76 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.54, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biocardia will likely underperform. At this point, Biocardia has a negative expected return of -0.0518%. Please make sure to confirm Biocardia's maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to decide if Biocardia performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.63 |
Good predictability
Biocardia has good predictability. Overlapping area represents the amount of predictability between Biocardia time series from 14th of December 2022 to 9th of December 2023 and 9th of December 2023 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biocardia price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Biocardia price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 5.37 |
Biocardia lagged returns against current returns
Autocorrelation, which is Biocardia stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biocardia's stock expected returns. We can calculate the autocorrelation of Biocardia returns to help us make a trade decision. For example, suppose you find that Biocardia has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biocardia regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biocardia stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biocardia stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biocardia stock over time.
Current vs Lagged Prices |
| Timeline |
Biocardia Lagged Returns
When evaluating Biocardia's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biocardia stock have on its future price. Biocardia autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biocardia autocorrelation shows the relationship between Biocardia stock current value and its past values and can show if there is a momentum factor associated with investing in Biocardia.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biocardia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biocardia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocardia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocardia Stock:Check out Biocardia Correlation, Biocardia Volatility and Biocardia Alpha and Beta module to complement your research on Biocardia. For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Biocardia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.